Document is current
Any future updates will be listed below
-
Authors
Lombardo, Gérôme
Lechanteur, Chantal
Briquet, Alexandra
Seidel, Laurence
Willems, Evelyne
Servais, Sophie
Baudoux, Etienne
Kerre, Tessa
Zachee, Pierre
Herman, Julie
Janssen, Audrey
Muller, Joséphine
Baron, Frédéric
Beguin, Yves https://orcid.org/0000-0003-4650-7520
-
Funding
Funding for this research was provided by:
Fonds De La Recherche Scientifique - FNRS
Fondation contre le Cancer
Université de Liège
Centre Hospitalier Universitaire de Liège
Fonds Léon Fredericq
- License Information
-
More Information
Article History
Received: 17 September 2024
Accepted: 14 November 2024
First Online: 3 December 2024
Declarations
:
: The protocol “Co-transplantation of mesenchymal stem cells and HLA-mismatched allogeneic hematopoietic cells after nonmyeloablative conditioning: a phase II randomized double-blind study” was approved centrally by the “Comité d’Ethique Hospitalo-Facultaire Universitaire de Liège” on 6 July 2010 (file 2010/16) as well as by the ethics committees of all participating centers and the study was conducted in accordance with the Declaration of Helsinki. Before participating in the study, all patients (or their legal representatives if minors) signed an informed consent form.
: Not applicable.
: The authors declare that they have no competing interests.
